Abivax SA American Share... (ABVX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Abivax SA American Shares Statistics
Share Statistics
Abivax SA American Shares has 63.35M shares outstanding. The number of shares has increased by 0.7% in one year.
Shares Outstanding | 63.35M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.08% |
Owned by Institutions (%) | n/a |
Shares Floating | 55.10M |
Failed to Deliver (FTD) Shares | 37 |
FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 577.23K, so 0.91% of the outstanding shares have been sold short.
Short Interest | 577.23K |
Short % of Shares Out | 0.91% |
Short % of Float | 1.05% |
Short Ratio (days to cover) | 4.75 |
Valuation Ratios
The PE ratio is -2.86 and the forward PE ratio is -3.42.
PE Ratio | -2.86 |
Forward PE | -3.42 |
PS Ratio | 91.52 |
Forward PS | 83 |
PB Ratio | 2.16 |
P/FCF Ratio | -4.34 |
PEG Ratio | n/a |
Enterprise Valuation
Abivax SA American Shares has an Enterprise Value (EV) of 220.41M.
EV / Earnings | -1.49 |
EV / Sales | 47.7 |
EV / EBITDA | -1.65 |
EV / EBIT | -1.73 |
EV / FCF | -2.2 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.28.
Current Ratio | 4.08 |
Quick Ratio | 4.08 |
Debt / Equity | 0.28 |
Total Debt / Capitalization | 22.06 |
Cash Flow / Debt | -1.75 |
Interest Coverage | -9.21 |
Financial Efficiency
Return on equity (ROE) is -0.75% and return on capital (ROIC) is -49.16%.
Return on Equity (ROE) | -0.75% |
Return on Assets (ROA) | -0.45% |
Return on Capital (ROIC) | -49.16% |
Revenue Per Employee | 74.53K |
Profits Per Employee | -2.38M |
Employee Count | 62 |
Asset Turnover | 0.01 |
Inventory Turnover | -128.13 |
Taxes
Income Tax | -4.49M |
Effective Tax Rate | 0.03 |
Stock Price Statistics
The stock price has increased by -47.43% in the last 52 weeks. The beta is 1.42, so Abivax SA American Shares's price volatility has been higher than the market average.
Beta | 1.42 |
52-Week Price Change | -47.43% |
50-Day Moving Average | 8.03 |
200-Day Moving Average | 11.42 |
Relative Strength Index (RSI) | 33.54 |
Average Volume (20 Days) | 142.63K |
Income Statement
In the last 12 months, Abivax SA American Shares had revenue of 4.62M and earned -147.74M in profits. Earnings per share was -3.43.
Revenue | 4.62M |
Gross Profit | 3.91M |
Operating Income | -127.38M |
Net Income | -147.74M |
EBITDA | -133.21M |
EBIT | -127.38M |
Earnings Per Share (EPS) | -3.43 |
Balance Sheet
The company has 251.94M in cash and 55.46M in debt, giving a net cash position of 196.48M.
Cash & Cash Equivalents | 251.94M |
Total Debt | 55.46M |
Net Cash | 196.48M |
Retained Earnings | -282.95M |
Total Assets | 327.06M |
Working Capital | 215.93M |
Cash Flow
In the last 12 months, operating cash flow was -100.01M and capital expenditures -265.00K, giving a free cash flow of -100.28M.
Operating Cash Flow | -100.01M |
Capital Expenditures | -265.00K |
Free Cash Flow | -100.28M |
FCF Per Share | -2.26 |
Margins
Gross margin is 97.23%, with operating and profit margins of -2.76K% and -3.20K%.
Gross Margin | 97.23% |
Operating Margin | -2.76K% |
Pretax Margin | -3.29K% |
Profit Margin | -3.20K% |
EBITDA Margin | -2.88K% |
EBIT Margin | -2.76K% |
FCF Margin | -2.17K% |
Dividends & Yields
ABVX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -54.88% |
FCF Yield | -25.32% |
Analyst Forecast
The average price target for ABVX is $43, which is 588% higher than the current price. The consensus rating is "Buy".
Price Target | $43 |
Price Target Difference | 588% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Scores
Altman Z-Score | -0.54 |
Piotroski F-Score | 2 |